Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFUS-144 injection for postoperative analgesia (phase II, randomized, double-blind, placebo/active-controlled)
CTR20254551Phase 2Active
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RFUS-144 in postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Nov 2025; status: active.
02
Drugs
RFUS-144
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20254551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254551.